Scapa continues to deliver positive results, despite the generally subdued economic environment. In Healthcare, strong operational progress continues and the acquisition of Euromed for $35m will broaden Scapa’s product offering. In Industrial, efficiency gains and asset optimisation continue to positively affect the margin. We upgraded in April and today upgrade again for underlying momentum and the Euromed acquisition. Momentum is strong and we continue to see the potential for strong growth op ....